International Stem Cell (OTCMKTS:ISCO) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.21 and traded as high as $0.33. International Stem Cell shares last traded at $0.33, with a volume of 100 shares.

International Stem Cell Price Performance

The business’s fifty day simple moving average is $0.31 and its two-hundred day simple moving average is $0.21. The company has a market cap of $2.88 million and a PE ratio of -4.50.

International Stem Cell (OTCMKTS:ISCO) last posted its earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $2.67 million for the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.